Evidence map›Paper›PMID 24922127›Full record

SynthesisAmerican journal of public health2014

Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D.

Cedric F Garland, June Jiwon Kim, Sharif Burgette Mohr, Edward Doerr Gorham, William B Grant, Edward L Giovannucci, Leo Baggerly, Heather Hofflich, Joe Wesley Ramsdell, Kenneth Zeng and 1 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in American journal of public health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Vitamin D Status and Mortality: A Systematic Review of Observational Studies.International journal of environmental research and public health · 2019
    Pooled it
  8. Guideline
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Evolution of Serum 25OHD in Response to Vitamin DJournal of the American College of Nutrition · 2018
    Trial
  14. Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Trial
  15. Trial
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Cedric F GarlandCedric F. Garland and Edward D. Gorham are with the Division of Epidemiology, Department of Family and Preventive Medicine, University of California San Diego, La Jolla. June J. Kim, Sharif B. Mohr, and Kenneth Zeng are with Leidos Biomedical Research, Inc., San Diego. William B. Grant is with Sunlight and Nutrition Research Center, San Francisco, CA. Edward L. Giovannucci is with departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, MA. Leo Baggerly is with Research Department, GrassrootsHealth, San Diego. Heather Hofflich and Joe W. Ramsdell are with Internal Medicine Group, Department of Medicine, University of California San Diego. Robert P. Heaney is with Department of Medicine, Creighton University, Omaha, NE.
June Jiwon Kim
Sharif Burgette Mohr
Edward Doerr Gorham
William B Grant
Edward L Giovannucci
Leo Baggerly
Heather Hofflich
Joe Wesley Ramsdell
Kenneth Zeng
Robert P Heaney

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We examined the relationship between serum 25-hydroxyvitamin D (25[OH]D) and all-cause mortality. We searched biomedical databases for articles that assessed 2 or more categories of 25(OH)D from January 1, 1966, to January 15, 2013. We identified 32 studies and pooled the data. The hazard ratio for all-cause mortality comparing the lowest (0-9 nanograms per milliliter [ng/mL]) to the highest (> 30 ng/mL) category of 25(OH)D was 1.9 (95% confidence interval = 1.6, 2.2; P < .001). Serum 25(OH)D concentrations less than or equal to 30 ng/mL were associated with higher all-cause mortality than concentrations greater than 30 ng/mL (P < .01). Our findings agree with a National Academy of Sciences report, except the cutoff point for all-cause mortality reduction in this analysis was greater than 30 ng/mL rather than greater than 20 ng/mL.

Indexed as

MortalityHumansProportional Hazards ModelsVitamin DVitamin D Deficiency25-hydroxyvitamin DVitamin D

Identifiers

PMID24922127
PMCPMC4103214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.